CoChat

Clinical features and morphological characterization of 10 patients with noninsulinoma pancreatogenous hypoglycaemia syndrome (NIPHS)

Won, Justin G. S., Tseng, Hsiao‐Shan, Yang, An‐Hang, Tang, Kam‐Tsun, Jap, Tjin‐Shing, Lee, Chen Hsen, Lin, Hong‐Da, Burcus, Niculina, Pittenger, Gary, Vinik, Aaron · 2006 · Clinical Endocrinology
Cited by 109

The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.

Abstract

Summary: Objective Noninsulinoma pancreatogenous hypoglycaemia syndrome (NIPHS), characterized by postprandial neuroglycopaenia, negative prolonged fasts and negative perioperative localization studies for insulinoma, but positive selective arterial calcium stimulation tests and nesidioblastosis in the gradient‐guided resected pancreas, is a rare hypoglycaemic disorder of undetermined aetiology. We analysed the clinical, morphological and immunohistological features to further clarify the aetiology and pathogenesis of this rare disease. Patients Ten consecutive patients with NIPHS (nine men and one woman, aged 29–78 years) were included in the study. Six of the 10 received a gradient‐guided subtotal (70%) or distal (50%) pancreatectomy. In the remaining four patients, diazoxide treatment was initiated and the precise mechanism of its action was assessed by meal tests. Results All of the patients showed a combination of postprandial neuroglycopaenia, negative prolonged fasts (except one patient) and negative localization studies for insulinoma, but positive calcium stimulation tests and nesidioblastosis in the gradient‐guided resected pancreas. Immunohistological studies of the resected pancreatic tissues revealed neither an increased rate of proliferation of β‐cells nor an abnormal synthesis and/or processing of either proinsulin or amylin. Evidence of overexpression of the two pancreatic differentiation factors, PDX‐1 and Nkx‐6·1, as well as the calcium sensing receptor (CaSR) was absent. Nevertheless, abnormal expression of islet neogenesis‐associated protein (INGAP), a human cytokine expressed only in the presence of islet neogenesis, in ducts and/or islets, was identified in three of the five patients studied. All of the six patients who received a surgical operation were relieved of further neuroglycopaenic attacks, but one patient who received a subtotal pancreatectomy developed diabetes. In the remaining four patients who received diazoxide treatment, hypoglycaemic episodes were satisfactorily controlled with an attenuated response of β‐cell peptides to meal stimulation. Conclusions Our results strengthen the existence of this unique clinical hypoglycaemic syndrome from β‐cell hyperfunction as well as the value of the selective arterial calcium stimulation test in its correct diagnosis and localization. The mechanisms underlying β‐cell hyperfunction and release of insulin to calcium, however, remain poorly characterized. Nevertheless, in a subset of patients with NIPHS, there exists some, as yet undefined, pancreatic humoral/paracrine factor(s) other than proinsulin, amylin, PDX‐1, Nkx‐6·1 and possibly glucagon‐like peptide‐1 (GLP‐1) that are capable of inducing the INGAP gene and, if activated, will initiate ductal proliferation and islet neogenesis. As for the treatment, we recommend that diazoxide be tried first in each patient and, should it fail, a gradient‐guided subtotal or distal pancreatectomy be attempted.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1365-2265.2006.02629.x

Cites

19 of 19 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 19 references

Research works printed but not linked: 64

  1. 10.1016/S0889-8529(18)30388-8 · DOI
  2. 10.1016/S0031-3955(05)70481-8 · DOI · Paper page
  3. 10.1056/NEJM199904153401505 · DOI · Paper page
  4. Sempoux C., 1998, Pancreatic B‐cell proliferation in persistent hyperinsulinemic hypoglycemia of infancy: an immunohistochemical study of 18 cases, Modern Pathology, 11, 444
  5. 10.1136/fn.82.2.F108 · DOI · Paper page
  6. 10.1007/PL00008192 · DOI
  7. Thomas P.M., 1996, Inactivation of the first nucleotide‐binding fold of the sulfonylurea receptor, and familial persistent hyperinsulinemic hypoglycemia of infancy, American Journal of Human Genetics, 59, 510
  8. 10.2337/diab.46.11.1743 · DOI · Paper page
  9. 10.1056/NEJM199703063361005 · DOI · Paper page
  10. 10.1172/JCI119594 · DOI · Paper page
  11. 10.1172/JCI4495 · DOI · Paper page
  12. 10.1136/adc.79.5.445 · DOI
  13. 10.1210/jc.84.5.1582 · DOI · Paper page
  14. 10.1016/S0039-6060(97)90228-2 · doi:10.1016/s0039-6060(97)90228-2
  15. 10.1177/002215549804600602 · DOI · Paper page
  16. Semakula C., 2002, Hypoglycemia after pancreas transplantation: association with allograft nesidiodysplasia and expression of islet neogenesis‐associated peptide, Journal of Clinical Endocrinology and Metabolism, 87, 3548, 10.1210/jcem.87.8.8769 · doi:10.1210/jcem.87.8.8769
  17. Flatt P.R., 1994, New perspectives on the actions of sulphonylureas and hyperglycaemic sulphonamides on the pancreatic β‐cell, Diabete et Metabolisme (Paris), 20, 157
  18. 10.1002/(SICI)1096-9136(199711)14:11<985::AID-DIA483>3.0.CO;2-L · DOI · Paper page
  19. 10.1210/jc.85.11.3973 · doi:10.1210/jc.85.11.3973 · Paper page
  20. Hirshberg B., 2000, Forty‐eight‐hour fast: the diagnostic test for insulinoma, Journal of Clinical Endocrinology and Metabolism, 85, 3222, 10.1210/jcem.85.9.6807 · DOI · Paper page
  21. 10.1148/radiology.178.1.1984311 · DOI · Paper page
  22. 10.7326/0003-4819-123-4-199508150-00004 · DOI · Paper page
  23. 10.1210/jc.81.4.1623 · DOI · Paper page
  24. 10.1007/BF00572826 · DOI
  25. 10.1016/S0026-0495(03)00200-2 · DOI
  26. 10.1016/0026-0495(93)90168-N · DOI
  27. 10.1210/jc.82.9.2899 · doi:10.1210/jc.82.9.2899
  28. 10.1093/ajcp/91.3.336 · DOI · Paper page
  29. 10.1016/S0889-8529(05)70086-4 · DOI
  30. 10.1056/NEJM198405033101807 · DOI · Paper page
  31. 10.1210/jc.79.1.290 · doi:10.1210/jc.79.1.290
  32. 10.1210/jc.80.6.1956 · doi:10.1210/jc.80.6.1956
  33. 10.1016/S0889-8529(18)30164-6 · DOI
  34. 10.1016/S0002-9343(99)00021-2 · DOI · Paper page
  35. 10.1136/adc.78.4.359 · DOI
  36. 10.1067/mpd.2000.107386 · DOI
  37. 10.1210/jc.2003-030965 · DOI · Paper page
  38. 10.1210/jc.2003-030941 · doi:10.1210/jc.2003-030941
  39. 10.1097/00000658-197910000-00009 · DOI
  40. Goebel S.U., 2000, Expression of the calcium‐sensing receptor in gastrinomas, Journal of Clinical Endocrinology and Metabolism, 85, 4131, 10.1210/jcem.85.11.6963 · doi:10.1210/jcem.85.11.6963
  41. 10.1016/S1726-4901(09)70140-6 · DOI
  42. Laidlaw G.F., 1938, Nesidioblastoma, the islet cell tumor of the pancreas, American Journal of Pathology, 14, 125
  43. 10.2337/diacare.12.2.108 · DOI · Paper page
  44. McHenry C., 1989, Adult nesidioblastosis: an unusual cause of fasting hypoglycemia, The American Surgeon, 55, 366
  45. 10.2337/diacare.18.10.1379 · DOI
  46. 10.1507/endocrj.43.163 · DOI · Paper page
  47. 10.1007/s004280050476 · DOI
  48. 10.1007/BF00427003 · DOI
  49. 10.1093/ajcp/84.4.534 · DOI · Paper page
  50. Scully R.E., 1983, Case records of the Massachusetts General Hospital. Case 1‐1983, New England Journal of Medicine, 308, 30
  51. 10.1007/BF01654938 · DOI · Paper page
  52. 10.1002/1097-0142(19860501)57:9<1824::AID-CNCR2820570920>3.0.CO;2-Q · DOI
  53. 10.1001/archsurg.1994.01420270107022 · DOI
  54. 10.1093/ajcp/78.4.511 · DOI · Paper page
  55. 10.1136/pgmj.68.799.389-a · DOI
  56. 10.1007/BF00202885 · DOI
  57. 10.2337/diabetes.50.4.785 · DOI · Paper page
  58. 10.1210/endo.143.8.8973 · DOI · Paper page
  59. 10.1056/NEJM200511173532017 · DOI · Paper page
  60. 10.1056/NEJMe058170 · DOI · Paper page
  61. Rafaeloff‐Phail R., 1998, INGAP is a human cytokine expressed only in the presence of islet neogenesis, Diabetes, 47, A259
  62. 10.1172/JCI119383 · DOI · Paper page
  63. Zangen D.H., 1997, Reduced insulin, GLUT2, and IDX‐1 in β‐cells after partial pancreatectomy, Diabetes, 46, 258, 10.2337/diab.46.2.258 · DOI · Paper page
  64. 10.1210/en.2003-0056 · DOI · Paper page

Cited by

Metadata

Authors
Won, J. G. S., Tseng, H., Yang, A., Tang, K., Jap, T., Lee, C. H., Lin, H., Burcus, N., Pittenger, G., & Vinik, A.
Venue
Clinical Endocrinology
Publisher
Wiley
Published
2006-08-04
Volume
65
Issue
5
Pages
566-578
ISSN
  • 0300-0664 (ISSN-L)
  • 1365-2265
OpenAlex
W2128711027
Cited by
109
References
19
FWCI
6.86
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.